Nav Search

Redefining Innovation in Rare Disease Drug Development


Join 1776, Horizon Therapeutics and partners for a panel discussion and reception about the current rare disease drug development landscape. The program will provide expert discussion on innovative approaches to addressing the challenges to research and drug development in rare diseases. There are 30 million patients living with a rare disease in the US, the panel will also explore how stakeholders in the rare disease community may work together to close the innovation gap and address unmet medical needs for patients.